Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR".
Feldmann A, Arndt C, Bergmann R, Loff S, Cartellieri M, Bachmann D, Aliperta R, Hetzenecker M, Ludwig F, Albert S, Ziller-Walter P, Kegler A, Koristka S, Gärtner S, Schmitz M, Ehninger A, Ehninger G, Pietzsch J, Steinbach J, Bachmann M.
Feldmann A, et al. Among authors: cartellieri m.
Oncotarget. 2017 May 9;8(19):31368-31385. doi: 10.18632/oncotarget.15572.
Oncotarget. 2017.
PMID: 28404896
Free PMC article.